WO2023037165 - METHODS AND COMPOSITIONS FOR REDUCING NEUTROPHILS OR NEUTROPHIL INFILTRATION AT THE SITE OF DISEASE
National phase entry:
Publication Number
WO/2023/037165
Publication Date
16.03.2023
International Application No.
PCT/IB2022/000520
International Filing Date
07.09.2022
Title **
[English]
METHODS AND COMPOSITIONS FOR REDUCING NEUTROPHILS OR NEUTROPHIL INFILTRATION AT THE SITE OF DISEASE
[French]
MÉTHODES ET COMPOSITIONS POUR RÉDUIRE LES NEUTROPHILES OU L'INFILTRATION DE NEUTROPHILES AU NIVEAU DU SITE D'UNE MALADIE
Applicants **
GNUBIOTICS SCIENCES SA
SmartLab/Biopole, Bat SE-B
Route de la Corniche 5
1066 Epalinges, CH
Inventors
ADESOKAN, Adeyemi
Chemin du Boisy 38
1004 Lausanne, CH
Priority Data
63/241,457
07.09.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1028 | |
| EPO | Filing, Examination | 4585 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9487 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Provided herein are methods and compositions for reducing neutrophils and/or neutrophil infiltration at the site of disease using glycopeptide containing compositions.[French]
La présente invention concerne des méthodes et des compositions destinées à réduire les neutrophiles et/ou l'infiltration de neutrophiles au niveau du site d'une maladie à l'aide de compositions contenant des glycopeptides.